This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | United States |
| Wikipedia page | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
| Best overview URL | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
| Facebook username | gatesfoundation |
| LinkedIn username | bill-&-melinda-gates-foundation |
| Website | https://www.gatesfoundation.org/ |
| Donations URL | https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database |
| Twitter username | gatesfoundation |
| Page on philosophy informing donations | https://www.gatesfoundation.org/What-We-Do |
| Grant application process page | https://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ |
| Regularity with which donor updates donations data | continuous updates |
| Regularity with which Donations List Website updates donations data (after donor update) | irregular |
| Lag with which donor updates donations data | months |
| Lag with which Donations List Website updates donations data (after donor update) | years |
| Data entry method on Donations List Website | SQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing |
Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett
Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief
Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database
Full donor page for donor Bill and Melinda gates Foundation
| Item | Value |
|---|---|
| Country | |
| Facebook page | uct.ac.za |
| Website | http://www.uct.ac.za/ |
| Twitter username | UCT_news |
| Wikipedia page | https://en.wikipedia.org/wiki/University_of_Cape_Town |
Full donee page for donee University of Cape Town
| Item | Value |
|---|
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 44 | 308,000 | 1,343,588 | -1,964,052 | 8,213 | 25,000 | 50,275 | 100,000 | 308,000 | 564,018 | 1,850,055 | 2,481,898 | 4,236,894 | 7,567,425 |
| Global health | 43 | 340,419 | 1,372,508 | -1,964,052 | 8,213 | 25,000 | 29,285 | 100,000 | 340,419 | 564,018 | 1,999,951 | 2,481,898 | 4,236,894 | 7,567,425 |
| Family planning | 1 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.
Note: Cause area classification used here may not match that used by donor for all cases.
| Cause area | Number of donations | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global health (filter this donor) | 43 | 59,017,852.00 | 3,770,390.00 | 2,986,638.00 | 9,097,955.00 | 4,578,249.00 | 7,665,448.00 | 12,821,374.00 | 5,054,599.00 | 7,567,388.00 | 5,375,811.00 | 100,000.00 |
| Family planning (filter this donor) | 1 | 100,000.00 | 0.00 | 0.00 | 100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 44 | 59,117,852.00 | 3,770,390.00 | 2,986,638.00 | 9,197,955.00 | 4,578,249.00 | 7,665,448.00 | 12,821,374.00 | 5,054,599.00 | 7,567,388.00 | 5,375,811.00 | 100,000.00 |
Graph of spending by cause area and year (incremental, not cumulative)
Graph of spending by cause area and year (cumulative)
There are no documents associated with this combination of donor and donee.
Graph of all donations (with known year of donation), showing the timeframe of donations
| Amount (current USD) | Amount rank (out of 44) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|
| 1,850,054.50 | 14 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop optimized drug leads for Malaria and Tuberculosis infections for use in high disease burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,850,054.50 | 14 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop optimized drug leads for Malaria and Tuberculosis infections for use in high disease burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 70,281.00 | 30 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to identify prospective immune correlates of risk of tuberculosis (TB) disease following natural infection with Mycobacterium tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 413,638.00 | 21 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to understand the biological mechanisms of successful or failed control of Mtb infection and generate testable hypotheses to lead to new interventions against tuberculosis, such as novel TB vaccines and/or other new preventive strategies; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 2,265,000.00 | 12 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to establish a PET/CT imaging facility at the University of Cape Town to monitor treatment response and predict relapse of tuberculosis patients; Aid type: Contributions to specific-purpose programmes and funds managed by implementing partners. Affected countries: South Africa. | |
| 308,000.00 | 23 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to support a longitudinal cohort study of children evaluating the number, severity, and etiology of respiratory disease, and evaluate the potential effect modifiers that may influence the incidence and severity of acute lower respiratory infections; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 4,236,893.50 | 5 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop an integrated health information system that improves health system performance and clinical care for patients with tuberculosis and / or human immunodeficiency virus infection; Aid type: Project-type interventions. Affected countries: South Africa. | |
| 4,236,893.50 | 5 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop an integrated health information system that improves health system performance and clinical care for patients with tuberculosis and / or human immunodeficiency virus infection; Aid type: Project-type interventions. Affected countries: South Africa. | |
| 549,794.00 | 19 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to identify prospective immune correlates of risk of tuberculosis (TB) disease following natural infection with Mycobacterium tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 26 | Family planning | https://iatiregistry.org/publisher/bmgf | -- | to increase the use of contraceptives, particularly over the long term, across South Africa by using a multisensory approach to explore how different contraceptives are perceived and identify barriers against uptake; Aid type: Project-type interventions. Affected countries: South Africa. | |
| 24,543.42 | 37 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to support the third H3D Symposium in South Africa in 2016. Third H3D Symposium 2016. Investment start date: 3/14/2016 to end date: 1/31/2017. Grantee name: University of Cape Town; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 24,543.42 | 37 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to support the third H3D Symposium in South Africa in 2016. Third H3D Symposium 2016. Investment start date: 3/14/2016 to end date: 1/31/2017. Grantee name: University of Cape Town; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 25,287.16 | 35 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support the third H3D Symposium in South Africa in 2016. Third H3D Symposium 2016. Investment start date: 3/14/2016 to end date: 1/31/2017. Grantee name: University of Cape Town; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 249,889.00 | 24 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to investigate the genotypic characteristics of aerosolized MTB bacilli in order to better understand and ultimately to design interventions to prevent aerosolized transmission; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 817,384.00 | 17 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to determine signatures of risk of tuberculosis (TB) disease, to ultimately be used for targeted therapy of persons subclinically infected with Mycobacterium tuberculosis (Mtb), and for enrollment of participants into trials of new TB vaccines; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 3,510,976.00 | 8 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop methodologies that ultimately will allow the identification of better and shorter treatment regimens for tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| -1,964,052.00 | 44 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to design, construct and establish a functional facility for the exposure of guinea pigs to airborne Mycobacteria tuberculosis generated by patients with active pulmonary tuberculosis; Aid type: Project-type interventions. Affected countries: South Africa. | |
| 564,018.00 | 18 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to identify prospective immune correlates of risk of tuberculosis (TB) disease following natural infection with Mycobacterium tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,999,951.00 | 13 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to assemble a multidisciplinary team to address systematically the bacterial, host and environmental factors, which contribute to tuberculosis (TB) transmission in high-burden regions; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: South Africa. | |
| 223,577.00 | 25 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to contribute to control of the global Tuberculosis (TB) epidemic by designing a clinical trial to test a Correlates of Risk-targeted screen-and-treat strategy, which will identify people at highest risk of developing TB disease and treat them, before the; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified; affected countries: South Africa. | |
| 340,419.00 | 22 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to fund an interim fellow at the University of Cape Town. Support of SATVI Clinical Immunology Capacity. Investment start date: 7/31/2014 to end date: 7/31/2018. Grantee name: University of Cape Town; Aid type: Project-type interventions. Affected countries: South Africa. | |
| 6,501,535.00 | 2 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to support a longitudinal cohort study of children evaluating the number, severity, and etiology of respiratory disease, and evaluate the potential effect modifiers that may influence the incidence and severity of acute lower respiratory infections; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 2,481,898.00 | 9 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop optimized drug leads for Malaria and Tuberculosis infections for use in high disease burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 508,471.00 | 20 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to describe treatment delays between identification of RR by Xpert and start of MDR-TB treatment and determine the critical points along this pathway at which delay occurs; Aid type: Project-type interventions. Affected countries: South Africa. | |
| 2,464,052.00 | 11 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to design, construct and establish a functional facility for the exposure of guinea pigs to airborne Mycobacteria tuberculosis generated by patients with active pulmonary tuberculosis; Aid type: Project-type interventions. Affected countries: South Africa. | |
| 74,959.00 | 29 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to convene an international symposium on innovative approaches to tuberculosis (TB) drug discovery that embrace translational medicine i.e. from the laboratory to the clinic and from the clinic to the laboratory; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 2,481,898.00 | 9 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop optimized drug leads for Malaria and Tuberculosis infections for use in high disease burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,074,924.00 | 16 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to identify predictive gene expression signatures of risk of tuberculosis (TB) disease, following natural infection with Mycobacterium tuberculosis (M.tb); these signatures will facilitate rapid screening of new, better TB vaccine candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 3,735,172.00 | 7 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to identify prospective immune correlates of risk of tuberculosis (TB) disease following natural infection with Mycobacterium tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 4,772,781.00 | 4 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to determine signatures of risk of tuberculosis (TB) disease, to ultimately be used for targeted therapy of persons subclinically infected with Mycobacterium tuberculosis (Mtb), and for enrollment of participants into trials of new TB vaccines; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 26 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to investigate how different progestins currently used in contraceptives might affect susceptibility to and transmission of HIV-1.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 29,285.00 | 32 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to convene a meeting of the previous GC6-74 consortium to consolidate future foundation funded activities, and to plan future, complementary activities, to be funded from other sources.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 7,971.81 | 41 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to convene an international conference to foster communication and training among African immunologists. Specific focus areas will include HIV, TB, and malaria, vaccinology, and non-communicable and veterinary diseases.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified|South of Sahara. | |
| 8,213.38 | 40 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to convene an international conference to foster communication and training among African immunologists. Specific focus areas will include HIV, TB, and malaria, vaccinology, and non-communicable and veterinary diseases.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified|South of Sahara. | |
| 7,971.81 | 41 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to convene an international conference to foster communication and training among African immunologists. Specific focus areas will include HIV, TB, and malaria, vaccinology, and non-communicable and veterinary diseases.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified|South of Sahara. | |
| 25,000.00 | 36 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to convene an international conference on global progress regarding the development of new TB vaccines; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 26,550.50 | 33 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to convene an international symposium in South Africa on new paradigms in drug discovery relating to two Foundation priority diseases prevalent in Africa and in developing countries, malaria and tuberculosis.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 26,550.50 | 33 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to convene an international symposium in South Africa on new paradigms in drug discovery relating to two Foundation priority diseases prevalent in Africa and in developing countries, malaria and tuberculosis.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 50,275.00 | 31 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to support African delegates to the International African Vaccinology Conference. International African Vaccinology Conference. Investment start date: 3/27/2012 to end date: 12/31/2012. Grantee name: University of Cape Town; Aid type: Project-type interventions. Affected regions: Africa. | |
| -37.00 | 43 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | for conference support. Conference Grant. Investment start date: 11/17/2010 to end date: 3/31/2011. Grantee name: University of Cape Town; Aid type: Project-type interventions. Affected regions: Africa. | |
| 7,567,425.00 | 1 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to support a longitudinal cohort study of children evaluating the number, severity, and etiology of respiratory disease, and evaluate the potential effect modifiers that may influence the incidence and severity of acute lower respiratory infections; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 23,000.00 | 39 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | for conference support. Conference Grant. Investment start date: 11/17/2010 to end date: 3/31/2011. Grantee name: University of Cape Town; Aid type: Project-type interventions. Affected regions: Africa. | |
| 5,352,811.00 | 3 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to identify predictive gene expression signatures of risk of tuberculosis (TB) disease, following natural infection with Mycobacterium tuberculosis (M.tb); these signatures will facilitate rapid screening of new, better TB vaccine candidates; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 26 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to attempt to disrupt the biosynthetic pathway of mycothiol, which is produced by tuberculosis as a protective chemical. Targeting this metabolic pathway specific to mycobacteria, might eliminate latent tuberculosis or make it more vulnerable.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |